1. Home
  2. BOLD vs PPSI Comparison

BOLD vs PPSI Comparison

Compare BOLD & PPSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • PPSI
  • Stock Information
  • Founded
  • BOLD 2018
  • PPSI 2008
  • Country
  • BOLD United States
  • PPSI United States
  • Employees
  • BOLD N/A
  • PPSI N/A
  • Industry
  • BOLD
  • PPSI Electrical Products
  • Sector
  • BOLD
  • PPSI Industrials
  • Exchange
  • BOLD Nasdaq
  • PPSI Nasdaq
  • Market Cap
  • BOLD 24.4M
  • PPSI 30.0M
  • IPO Year
  • BOLD 2024
  • PPSI N/A
  • Fundamental
  • Price
  • BOLD $1.19
  • PPSI $3.30
  • Analyst Decision
  • BOLD Buy
  • PPSI Strong Buy
  • Analyst Count
  • BOLD 3
  • PPSI 1
  • Target Price
  • BOLD $4.00
  • PPSI $12.00
  • AVG Volume (30 Days)
  • BOLD 105.5K
  • PPSI 69.3K
  • Earning Date
  • BOLD 08-11-2025
  • PPSI 09-09-2025
  • Dividend Yield
  • BOLD N/A
  • PPSI 45.73%
  • EPS Growth
  • BOLD N/A
  • PPSI N/A
  • EPS
  • BOLD N/A
  • PPSI 2.84
  • Revenue
  • BOLD N/A
  • PPSI $26,304,000.00
  • Revenue This Year
  • BOLD N/A
  • PPSI $24.01
  • Revenue Next Year
  • BOLD N/A
  • PPSI $19.25
  • P/E Ratio
  • BOLD N/A
  • PPSI $1.15
  • Revenue Growth
  • BOLD N/A
  • PPSI 439.46
  • 52 Week Low
  • BOLD $1.00
  • PPSI $2.25
  • 52 Week High
  • BOLD $4.72
  • PPSI $7.00
  • Technical
  • Relative Strength Index (RSI)
  • BOLD N/A
  • PPSI 56.68
  • Support Level
  • BOLD N/A
  • PPSI $3.51
  • Resistance Level
  • BOLD N/A
  • PPSI $3.94
  • Average True Range (ATR)
  • BOLD 0.00
  • PPSI 0.22
  • MACD
  • BOLD 0.00
  • PPSI 0.03
  • Stochastic Oscillator
  • BOLD 0.00
  • PPSI 46.77

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About PPSI Pioneer Power Solutions Inc.

Pioneer Power Solutions Inc designs, manufactures, integrates, services, and sells distributed energy resources, on-site and mobile power generation equipment, and a platform of mobile electric vehicle (EV) charging solutions.. Its principal products and services include custom-engineered electrical transformers, switchgear and engine-generator sets and controls, complemented by a national field-service network to maintain and repair power generation assets.

Share on Social Networks: